# Summary of Proposed Legislation
This document outlines a comprehensive U.S. legislative proposal with several key components:
1. **Research Restrictions**:
- Requires certification from Federal research grant recipients that they are not Chinese citizens or participants in Chinese talent programs
- Prohibits employment of Chinese nationals in federally funded research
- Requires institutions receiving Federal assistance to agree not to knowingly employ individuals participating in Chinese talent programs
2. **Foreign Gifts and Contracts Disclosure**:
- Mandates disclosure of foreign gifts/contracts over $50,000 to universities
- Requires public reporting of restricted/conditional gifts/contracts
- Creates a searchable public database of foreign gifts to universities
- Requires institutions to maintain policies regarding foreign gifts to faculty and staff
3. **Investment Restrictions**:
- Restricts tax-exempt organizations from holding investments in "disqualified Chinese companies" (defined as corporations incorporated in China or with significant Chinese government ownership)
- Requires annual reporting on such investments
- Allows limited waivers with public disclosure
4. **Taiwan Policy**:
- Prohibits U.S. government from recognizing PRC claims to sovereignty over Taiwan without Taiwan's consent
- Requires U.S. government to treat Taiwan's democratically elected government as the legitimate representative of the people of Taiwan
- Requires a strategy to protect U.S. businesses from Chinese coercion efforts
5. **Additional Provisions**:
- Requires participants in Chinese talent programs to register as agents of the Chinese government
- Amends economic espionage laws to include education and research
- Mandates disclosure of certain funds received by visa holders
The legislation represents a significant effort to limit Chinese influence in U.S. academic institutions, research, and business sectors while establishing a more robust policy framework regarding Taiwan.
HR 7427 clarifies that states may use Temporary Assistance for Needy Families (TANF) funds to support pregnancy centers and other "alternatives to abortion" programs that provide life-affirming services like counseling, parenting resources, and material support to pregnant individuals. The bill explicitly defines these programs as those promoting childbirth over abortion through services such as prenatal care coordination, job training, infant supplies, and adoption referrals, while excluding entities that provide or facilitate abortions. It also prohibits federal discrimination against grantees or states that fund such programs, including preventing the government from imposing unfair requirements or cutting funding based on a provider's opposition to abortion. This bill directly affects pregnancy centers, adoption agencies, and maternity homes receiving TANF funding, ensuring their eligibility under existing federal law. The legislation responds to a 2023 federal proposal that threatened to restrict such funding.
The MATCH IT Act of 2024 establishes national standards to improve patient matching accuracy in electronic health records. It requires the Secretary to create a uniform definition for measuring patient match rates (accounting for duplicate/overlaid records) and develop a minimum data set to support 99.9% matching accuracy by healthcare systems. The bill mandates incorporating this data set into health IT certification requirements and Medicare interoperability programs within 18-24 months. It also creates a voluntary Medicare bonus for providers meeting 90% patient match rates, with anonymous reporting of accuracy data. This directly affects healthcare providers, health IT vendors, and Medicare participants by requiring standardized matching protocols to reduce medical errors and costs linked to misidentification.
This bill removes a requirement for ambulatory surgical centers participating in Medicare to report the COVID-19 vaccination status of their healthcare workers. Specifically, it directs the Secretary of Health and Human Services to revise Medicare regulations (42 CFR §§ 416.300-416.330) within 45 days of enactment to eliminate this reporting mandate. The change directly affects ambulatory surgical centers that receive Medicare funding, removing a specific administrative burden related to employee vaccination data. The bill focuses solely on modifying existing reporting rules, with no new funding or program requirements.
This bill changes the negotiation period for small-molecule drugs under the federal Drug Price Negotiation Program from 7 years to 11 years, matching the existing 11-year period for biologic drugs. It directly affects drug manufacturers participating in the program by extending the timeframe for price negotiations with the government. The amendment applies to all small-molecule drugs covered under the program, creating a uniform negotiation timeline for both drug types. The change takes effect as if included in the Inflation Reduction Act of 2022.
HR 7142 (Alternatives to PAIN Act) requires Medicare Part D plans to cover non-opioid pain management drugs with no deductible and at the lowest copay level starting in 2025. It defines "qualifying non-opioid drugs" as FDA-approved medications that don’t act on opioid receptors (like certain NSAIDs or nerve pain treatments), excluding opioids and schedule I-III drugs. The bill prohibits Medicare plans from forcing patients to try opioids first (step therapy) or requiring prior approval for these non-opioid options. It directly affects Medicare beneficiaries needing pain management, especially those seeking alternatives to opioids for post-surgical or acute pain. The policy change aims to improve access to non-addictive pain treatments while preserving doctors' authority to prescribe medically appropriate care.
The EASE Act of 2024 requires the Centers for Medicare & Medicaid Services (CMS) to test a new model improving access to specialty health care for Medicare and Medicaid beneficiaries in rural or underserved areas. It mandates CMS to partner with selected provider networks - comprising at least 50 community health clinics, nonprofits with proven community health work, and commitment to research - to deliver specialty care via telehealth and remote technology, coordinated with patients’ primary care providers. This model directly affects Medicare Part A/B beneficiaries and Medicaid enrollees living in designated underserved regions. The bill establishes specific criteria for network selection and defines "eligible individuals" based on coverage type and geographic location.
This bill amends Medicare eligibility rules to explicitly include occupational therapy as a qualifying service for home health care. It changes the Social Security Act to state that beneficiaries need "occupational, or speech therapy" (instead of only "speech therapy") to qualify for home health services. This change directly affects Medicare beneficiaries requiring occupational therapy at home, expanding access to this specific care. The policy takes effect for services provided on or after January 1, 2025.
HR 6790 establishes National Institutes of Health centers to advance research, early detection, and public awareness of rare kidney diseases, with a focus on rural and underserved communities. It mandates a federal study on genetic testing barriers, treatment patterns, and public awareness for rare kidney diseases affecting disproportionately impacted populations, including barriers to insurance coverage and access to specialists. The bill also funds nephrology training programs to increase specialists serving these communities and requires experiments to delay or prevent the need for dialysis and transplants. Total funding of $7 million is authorized for fiscal years 2024-2028 to support these research, education, and early intervention efforts.
The Preserving Seniors’ Access to Physicians Act of 2023 increases the Medicare payment adjustment rate for physicians from 1.25% to 4.62%, directly affecting doctors who treat Medicare patients (primarily seniors). It also reduces the funding for the Medicaid improvement fund from $5,796,117,810 to $3,973,117,810. These changes impact Medicare providers and Medicaid programs, with the Medicare adjustment aimed at supporting physicians adjusting to payment changes. The bill does not specify how the Medicaid funding reduction relates to its stated goal of preserving seniors' access to physicians.
This bill protects religious child welfare providers from losing government contracts or funding if they refuse to provide services conflicting with their sincerely held religious beliefs (e.g., certain foster care or adoption placements). It prohibits states and federal agencies from denying contracts, licenses, or renewals for this reason, and allows providers to sue for violations with recovery of damages and legal fees. States violating the law risk losing 15% of federal child welfare funding. The law applies to all federally funded child welfare services, including foster care, adoption support, and family preservation programs.
The ARCH Act extends funding for two critical rural hospital payment programs through 2029 (instead of 2024). It directly affects rural hospitals classified as Medicare-dependent hospitals (MDHs) or low-volume hospitals (LVHs), ensuring continued financial support. Key provisions include extending payment methodologies, allowing hospitals to decline reclassification, and requiring a GAO report analyzing rural hospital classification overlaps and recommending improvements. The GAO must report within 180 days on classification criteria, overlaps, and potential changes to improve rural hospital sustainability and patient access.
